Intrinsiqs

Is Emergent BioSolutions Inc. overvalued?

Emergent BioSolutions Inc. (EBS) looks undervalued — trading about 305% below its fair value.

Undervalued
Current price $5.79 Fair value $23.47
Price
$5.79
Fair value
$23.47
Current P/E
5.8
Normal P/E
23.5
Market cap
$297.7M
Dividend yield
0.0%
Return on equity
-61.3%
Sector
Healthcare

See the full interactive analysis →

Fair value compares EBS's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.